Progressive addition lenses (PALs) continue to serve as a cornerstone of optical sales in most eyecare practices, representing a significant portion of revenue due to their complex design, perceived value, and customized fitting. Understanding regional pricing dynamics provides important context for evaluating both your market and your own pricing strategy. Factors such as manufacturing technology, patient perception, managed care influence, and local market competition all shape the pricing landscape.

This report builds on a 2022 analysis by incorporating the most recent data from calendar year 2024, offering a clearer picture of evolving PAL pricing trends across the United States.

There are several ways to categorize progressive lenses. A common approach is a binary classification of standard versus custom, which is often used to differentiate free-form (digital) progressive lenses. This classification may also refer to lenses that incorporate “as-worn” measurements—though these are frequently bypassed in favor of default values. Vision plans typically use their own proprietary groupings, usually four to five categories based on cost of goods. In this report, we focus on list price.

METHODS

We analyzed over 1.6 million anonymized and aggregated progressive lens sales from more than 2,000 practice locations across the U.S. during calendar year 2024. For each pair sold, we calculated the average list price. We then organized the results into price groupings and calculated both the average list price and the share of sales in each price bin, segmented by the nine U.S. Census Bureau divisions.

RESULTS

In 2024, the average list price per progressive lens pair sold was $663. Among the nine Census divisions, the East South Central region recorded the lowest average at $559, while the Pacific division reported the highest at $712.

To better understand distribution, we created five pricing bins to evaluate the share of units sold by price. Nationally:

• 11.2% of progressive lens pairs were sold below $400
• 18.0% fell in the $400–$549 range
• 45.4% were priced between $550–$799
• 21.5% ranged from $800–$1,049
• 3.8% exceeded $1,050

Users can select Census divisions at the top of the dashboard to explore changes in price distribution and average list prices by region. Hovering over or clicking on the map reveals the average list price, and selecting a range from the column chart further narrows the price view.

DISCUSSION

PAL pricing is both an art and a science. Finding the right balance between profitability and patient affordability requires a strong understanding of national and regional pricing trends. Since 2022, the average national list price has risen from $630 to $663. However, not all regions have followed this trend. The East South Central division, for instance, saw a notable decline—from $627 in 2022 to $559 in 2024—suggesting competitive pressure or deliberate pricing shifts. On the other hand, the Pacific division leads with an average price of $712, possibly due to higher-value offerings or distinct market dynamics.

These variations offer practices the opportunity to reassess their pricing strategy. If your pricing is on the lower end, consider repositioning premium products to improve margins while maintaining accessibility through tiered offerings. If your pricing is near or above market averages, it’s important to highlight differentiation in quality, warranties, or service to support the value of your higher pricing.

Ultimately, data-informed pricing helps providers protect margins, stay competitive, and build patient trust.

---